Q13490 (BIRC2_HUMAN) Homo sapiens (Human)

Baculoviral IAP repeat-containing protein 2 UniProtKBInterProSTRINGInteractive Modelling

618 aa; Sequence (Fasta) ; (Isoform 2); 1 identical sequence: Pan paniscus: A0A2R8Z7Y7

Available Structures

28 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The BIR3 domain of cIAP1 in complex with the N terminal peptide from SMAC/DIABLO (AVPIAQ).
3d9u
 Heteromer
Q9NR28; 		260-351
1×ZN;
Assess
Ternary complex structure - BTK cIAP compound 15
6w8i
 Heteromer
Q06187; 		260-351
1×ZN; 1×TKY;
Assess
Ternary complex structure - BTK cIAP compound 17
6w7o
 Heteromer
Q06187; 		260-350
1×TL7; 1×ZN;
Assess
Structure of cIAP1, BTK and BCCov
8dso
 Heteromer
Q06187; 		261-351
1×TOO; 1×ZN;
Assess
CIAP1-BIR3 in complex with N-terminal peptide from Caspase-9 (ATPFQE)
3d9t
 Heteromer
P55211; 		263-352
1×ZN;
Assess
Crystal structure of human BIRC2 BIR3 domain in complex with histone H3
7trl
 Heteromer
Q6NXT2; 		261-346
6×EDO; 1×ZN;
Assess
Crystal structure of cIAP1 RING domain bound to UbcH5B-Ub and a non-covalent Ub
6hpr
 Heteromer
P0CG47; P62837; 		556-618
2×ZN;
Assess
cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac037
3mup
homo-4-mer260-362
4×SMK; 4×ZN;
Assess
cIAP1-BIR3 in complex with a divalent Smac mimetic
4eb9
homo-2-mer260-362
2×ZN; 1×0O6;
Assess
IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization
3t6p
monomer265-616
3×ZN;
Assess
Structure of cIAP1 CARD
2l9m
monomer435-562
Assess
cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac066
3oz1
monomer259-361
1×ZN; 1×BMB;
Assess
Structure of cIAP1-BIR3 and inhibitor
4kmn
monomer260-357
1×ZN; 1×436; 1×PO4;
Assess
Crystal structure of cIAP1-BIR3 in complex with a covalently bound SM
6exw
monomer260-357
1×ZN; 1×C3K;
Assess
SOLUTION STRUCTURE OF A BACULOVIRAL INHIBITOR OF APOPTOSIS (IAP) REPEAT
1qbh
monomer266-363
1×ZN;
Assess
Small Molecule inhibitors of IAP
5m6n
monomer266-362
1×ZN; 2×SO4; 1×7H9;
Assess
Crystal structure of cIAP1 BIR3 bound to T3256336
4hy5
monomer260-352
1×ZN; 1×1AQ;
Assess
Crystal structure of cIAP1 BIR3 bound to T3258042
4mti
monomer260-352
1×ZN; 1×2DX;
Assess
Crystal structure of cIAP1 BIR3 bound to T3170284
4hy4
monomer261-352
1×ZN; 1×1BG;
Assess
Structure of cIAP1 with BCCov
8dsf
monomer260-351
1×ZN; 1×TO0;
Assess
Crystal structure of clAP1 BIR3 bound to T3261256
4lge
monomer261-352
1×ZN; 1×1Y0;
Assess
Crystal structure of cIAP1 BIR3 bound to T3450325
4mu7
monomer263-352
1×ZN; 1×2DY;
Assess
Crystal structure of clAP1 BIR3 bound to T3226692
4lgu
monomer263-352
1×ZN; 1×1YH;
Assess
Structure of cIAP with compound 15
6w74
monomer266-352
1×ZN; 1×TKY;
Assess
Crystal structure of human BIRC2 BIR3 domain in complex with inhibitor LCL-161
7trm
monomer261-345
1×ZN; 3×EDO; 1×IUN;
Assess
Apo structure of BIR2 Domain of BIRC2
7qgj
monomer175-252
1×ZN; 6×EDO;
Assess
Structure of BIR1 from cIAP1
3m1d
monomer41-118
1×ZN;
Assess
Crystal structure of cIAP1 BIR3 bound to GDC0152
3uw4
monomer267-343
2×ZN;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3t6p.1.Amonomer0.83265-616
3×ZN;98.55
Assess
2l9m.1.Amonomer0.66435-561
100.00
Assess
8fvu.1.Amonomer0.5240-254
1×ZN;33.33
Assess
8fml.1.Amonomer0.5195-349
28.90
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23t6p.1.Amonomer0.84216-567
3×ZN;98.55
Assess
Isoform 22l9m.1.Amonomer0.65386-512
100.00
Assess
Isoform 28fvu.1.Amonomer0.541-205
1×ZN;33.51
Assess